Biological and Clinical Changes in a Pediatric Series Treated with Off-Label JAK Inhibitors

Off-label use of medications is still a common practice in pediatric rheumatology. JAK inhibitors are authorized in adults in the treatment of rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Although their use is not authorized yet in children, JAK inhibitors, based on their mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Pin, Alessia, Tesser, Alessandra, Pastore, Serena, Moressa, Valentina, Valencic, Erica, Arbo, Anna, Maestro, Alessandra, Tommasini, Alberto, Taddio, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590237/
https://www.ncbi.nlm.nih.gov/pubmed/33092242
http://dx.doi.org/10.3390/ijms21207767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590237/
https://www.ncbi.nlm.nih.gov/pubmed/33092242
http://dx.doi.org/10.3390/ijms21207767

Ejemplares similares